Activated platelets as a possible early marker to predict clinical efficacy of leukocytapheresis in...
Activated platelets as a possible early marker to predict clinical efficacy of leukocytapheresis in severe ulcerative colitis patients
About this item
Full title
Author / Creator
Publisher
Japan: Springer Nature B.V
Journal title
Language
English
Formats
Publication information
Publisher
Japan: Springer Nature B.V
Subjects
More information
Scope and Contents
Contents
Leukocytapheresis (LCAP) is an effective adjunct for patients with active ulcerative colitis (UC). Because LCAP may have the potential to remove and modulate not only leukocytes but also platelets, we evaluated the correlation between activated platelets and the therapeutic response to LCAP.
Fourteen patients with severe UC received weekly LCAP...
Alternative Titles
Full title
Activated platelets as a possible early marker to predict clinical efficacy of leukocytapheresis in severe ulcerative colitis patients
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_68677050
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_68677050
Other Identifiers
ISSN
0944-1174
E-ISSN
1435-5922
DOI
10.1007/s00535-006-1789-y
